Search    ENTER KEYWORD
MSDS Material Safety Data Sheet
CAS

N/A

File Name: badgerminingcorp_com_March12007SilicaSandMSDSRevE.asp

                           Material Safety Data Sheet

Rev. E - Revised March 1, 2007

Section 1 鈥? Product Identification and Company Information
Trade Names: Trademarks and product names include Badger FracTM, Badger PacTM, Badger
CastTM, Badger GrindTM, and Badger Enviromedia. Products also generally
referred to as Taylor Silica, Fairwater Silica.
Common Names/Synonyms: Silica Sand
Product Use: Frac Sands, Gravel Pack Sands, Resin Coating Base Sands, Foundry Core and
Molding Sands, Industrial Sands, Glass Sands, Filtration Media, Environmental
Sands, Grinding Media, Industrial Fillers, Testing Sands, Recreational and
Agricultural Sands.
This product is not to be used for abrasive blasting. This material safety data
sheet and the information contained herein were not developed for abrasive
blasting.
Manufacturer鈥檚 Name: Badger Mining Corporation
Manufacturer鈥檚 Address: P.O. Box 328
409 South Church Street
Berlin, WI 54923
Manufacturer鈥檚 Telephone: 800-932-7263 (7:30 am 鈥? 5 pm Central Time Monday-Friday)
920-361-2388
Manufacturer鈥檚 Fax: 920-361-2826
Emergency Number: 800-932-7263 (7:30 am 鈥? 5 pm Central Time Monday-Friday)
920-361-2388

Section 2 鈥? Hazards Identification
Emergency Overview
Badger Mining Corporation Silica Sand is a light buff to white sand with no odor. It is not flammable, combustible,
or explosive. It can cause irritation to the eyes. A single exposure will not result in serious adverse health effects.
Crystalline silica is not known to be an environmental hazard.

Potential Health Effects
Inhalation:

a. Silicosis: Respirable crystalline silica (quartz) can cause chronic silicosis, a fibrosis (scarring) of the lungs.
Silicosis may be progressive; it may lead to disability and death. Acute Silicosis can occur with exposures to
very high concentrations of respirable crystalline silica over a very short time period, sometimes as short as a
few months. The symptoms of acute silicosis include progressive shortness of breath, fever, cough and weight
loss. Acute silicosis is fatal.

b. Cancer: Crystalline silica (quartz) inhaled from occupational sources in sufficient concentrations is classified
as carcinogenic to humans. In its Ninth Annual Report on Carcinogens, the National Toxicology Program
(NTP) listed crystalline silica as a known human carcinogen, based on sufficient evidence of carcinogenicity
from studies in humans indicating a causal relationship between exposure to respirable crystalline silica and
increased lung cancer rates in workers exposed to crystalline silica dust. The International Agency for
Research on Cancer (IARC) has evaluated crystalline silica and determined that 鈥渃rystalline silica inhaled in
the form of quartz or cristobalite from occupational sources is carcinogenic to humans (Group 1).鈥?

c. Autoimmune Diseases: There is evidence that exposure to respirable crystalline silica (without silicosis) or
that the disease silicosis may be associated with the increased incidence of several autoimmune disorders, --
scleroderma, systemic lupus erythematosus, rheumatoid arthritis and diseases affecting the kidneys.

d. Tuberculosis: Silicosis increases the risk of tuberculosis.




Page 1
Badger Mining Corporation Last Revised: March 2007
MSDS for Silica Sand

e. Nephrotoxicity: There is evidence that exposure to respirable crystalline silica (without silicosis) or that the
disease silicosis is associated with the increased incidence of kidney diseases, including end stage renal
disease.

Eye Contact: Crystalline silica (quartz) may cause abrasion of the cornea.

Skin Contact: May cause abrasion to skin.

Ingestion: No known health effect.

Acute Effects: One form of silicosis, Acute Silicosis, can occur with exposures to very high concentrations of respirable
crystalline silica over a very short time period, sometimes as short as a few months. The symptoms of acute silicosis
include progressive shortness of breath, fever, cough and weight loss. Acute silicosis is fatal.

Chronic Effects: The adverse health effects -鈥? lung disease, silicosis, cancer, autoimmune disease, tuberculosis, and
nephrotoxicity -- are chronic effects.

Signs and Symptoms of Exposure: There are generally no signs or symptoms of exposure to crystalline silica (quartz).
Often, chronic silicosis has no symptoms. The symptoms of chronic silicosis, if present, are shortness of breath,
wheezing, cough and sputum production. The symptoms of acute silicosis are the same as those associated with chronic
silicosis; additionally, weight loss and fever may also occur. The symptoms of scleroderma include thickening and
stiffness of the skin, particularly in the fingers, shortness of breath, difficulty swallowing and joint problems.

Medical Conditions Generally Aggravated by Exposure: The condition of individuals with lung disease (e.g.,
bronchitis, emphysema, chronic obstructive pulmonary disease) can be aggravated by exposure.

See Section 11, Toxicological Information, for additional detail on potential adverse health effects.

Section 3 鈥? Composition and Information on Ingredients
Hazardous Ingredients

Name: Silica, Quartz, SiO2
CAS Number: 14808 - 60- 7
Concentration (%) 89.0-99.9%

Section 4 鈥? First Aid Procedures
Inhalation 鈥? There is no specific treatment because the health effects associated with silica are chronic. If gross
inhalation of silica occurs, remove the person to fresh air, perform artificial respiration as needed, and obtain
medical attention as needed.

Eye 鈥? Wash the eye with water. If irritation persists, seek medical attention.

Skin 鈥? If abrasion occurs, seek medical attention.

Ingestion 鈥? If large amounts are ingested, seek medical attention.

Section 5 鈥? Fire Fighting Measures
Flashpoint: None
Upper/Lower Explosive Limit: Not Combustible
Autoignition Temperature: None
Unusual Fire and Explosion Habits: None
Extinguishing Media: Compatible with all media; use the medium appropriate to the
surrounding fire.
Special Fire Fighting Procedures: None with respect to this product.
Hazardous Combustion Products: None




Page 2
Badger Mining Corporation Last Revised: March 2007
MSDS for Silica Sand

Section 6 鈥? Accidental Release Measures
Wear appropriate personal protective equipment as described in Section 8 of this document. Collect the material
using a method that does not produce dust [High-Efficiency Particulate Air (HEPA) vacuum or thoroughly wetting
down the silica]. Place the silica in a covered container appropriate for disposal. Dispose of the silica according to
federal, state, and local regulations.

Section 7 鈥? Handling and Storage
This product is not to be used for abrasive blasting. Do not breathe dust, which may be created during the handling
of this product. Do not rely on vision to determine whether respirable silica is present in the air, as it may be present
without a visible cloud. Use good housekeeping procedures to prevent the accumulation of silica dust in the
workplace. Avoid the creation of respirable dust.

Use adequate ventilation and dust collection equipment. Ensure that the dust collection system is adequate to reduce
airborne dust levels to below the appropriate occupational health limit. Use respiratory protection during the
establishment of engineering controls. Refer to Section 8 - Exposure Controls/Personal Protection for further
information.

In accordance with the U.S. Occupational Safety and Health Administration鈥檚 (OSHA) Hazard Communication
Standard (29 CFR 1910.1200, 1915.99, 1917.28, 1918.90, 1926.59, 1928.21), state, and/or local right-to-know
laws and regulations, familiarize your employees with this MSDS and the information contained herein. Warn your
employees (and your customers in case of resale) of the potential health risks associated with the use of this product
and train them in the appropriate use of personal protective equipment and engineering controls, which will reduce
their risks of exposure.

See also ASTM International standard practice E 1132-06, "Standard Practice for Health Requirements Relating to
Occupational Exposure to Respirable Crystalline Silica."

Crystalline silica is listed by the Governor of the State of California, under Proposition 65, as requiring the following
warning: 鈥淒etectable amounts of chemicals known to the State of California to cause cancer, birth defects, or other
reproductive harm may be found in this product.鈥?

Section 8 鈥? Exposure Controls/Personal Protection
Exposure Limits (respirable fraction) in Air:
OSHA - PEL 10 mg/m3
% SiO2+2 (8-Hr. Time Weighted Average)
ACGIH 鈥? TLV 0.025 mg/m3 (8-Hr. Time Weighted Average)
NIOSH - REL 0.05 mg/m3 (10-Hr. Time Weighted Avg., 40-hr. work week)

Exposure Limits refer to the respirable fraction

Silica is classified as hazardous under Occupational Safety and Health Administration (OSHA) regulations (29 CFR
1910.1200).

CAUTION:
Crystalline silica exists in several forms, the most common of which is quartz. If crystalline silica (quartz) is heated to
more than 870掳C (1598掳F) it can change to a form of crystalline silica known as trydimite, and if crystalline silica
(quartz) is heated to more than 1470掳C (2678掳F), it can change to a form of crystalline silica known as cristobalite.
Crystalline silica as trydimite and cristobalite are more fibrogenic than crystalline silica as quartz. The OSHA PEL for
crystalline silica as trydimite and cristobalite is one-half the PEL for crystalline silica (quartz); the ACGIH TLV for
crystalline silica as cristobalite is equal to the TLV for crystalline silica as quartz. The ACGIH, in 2005, has withdrawn
the TLV for crystalline silica as trydimite.

Ventilation: Use local exhaust as required to maintain exposures below the occupational
exposure limits; see also ACGIH, Industrial Ventilation 鈥? Recommended Practice
(latest edition).




Page 3
Badger Mining Corporation Last Revised: March 2007
MSDS for Silica Sand

Respiratory Protection: This product is not to be used for abrasive blasting. Consult with OSHA
regulations and NIOSH recommendations to determine the appropriate
respiratory protection during use of this product. Use only NIOSH-approved
respiratory protection equipment. Avoid breathing dust produced during the use
and handling of this product. If the workplace airborne crystalline silica
concentration is unknown for a given task, conduct air monitoring to determine the
appropriate level of respiratory protection. Consult with a certified industrial
hygienist, your insurance risk manager, or the OSHA Consultative Services group
for detailed information. Ensure appropriate respirators are worn during and
following the task, including clean up or whenever airborne dust is present, to
ensure worker exposures remain below occupational health limits. Provisions
should be made for a respiratory protection training program (see 29 CFR
1910.134 鈥? Respiratory Protection for minimum program requirements). See
also ANSI standard Z88.2 (latest revision) "American National Standard for
Respiratory Protection," 29 CFR 1910.134 and 1926.103, and 42 CFR 84.

Gloves: Recommended in situations where abrasion from sand may occur.

Eye: Use protection as appropriate for the task at hand.

Other: Use protective clothing as appropriate for the work environment.

Section 9 鈥? Physical and Chemical Properties
Appearance: Light Buff to White Sand
Odor: None
Physical State: Granular Solid
pH: Not Applicable
Vapor Pressure Not Applicable
Vapor Density: Not Applicable
Boiling Point or Range, 掳F: 2230掳C (4046掳F) for Quartz
Melting Point or Range, 掳F: 1710掳C (3110掳F) for Quartz
Solubility In Water: Insoluble
Specific Gravity: 2.65 (Quartz)

Section 10 鈥? Stability and Reactivity
Stability: Stable
Materials to Avoid: Strong Oxidizing Agents, such as fluorine, chlorine trifluoride,
hydrogen fluoride, and oxygen difluoride.
Hazardous Decomposition Products: Silica will dissolve in hydrofluoric acid and produce a corrosive gas 鈥?
silicon tetrafluoride.
Hazardous Polymerization: Will not occur

Section 11 鈥? Toxicological Information
A. SILICOSIS
The major concern is silicosis (lung disease), caused by the inhalation and retention of respirable crystalline silica dust.
Silicosis can exist in several forms, chronic (or ordinary), accelerated, or acute.

Chronic or Ordinary Silicosis is the most common form of silicosis, and can occur after many years of exposure to
levels above the occupational exposure limits for airborne respirable crystalline silica dust. It is further defined as
either simple or complicated silicosis.

Simple silicosis is characterized by lung lesions (shown as radiographic opacities) less than 1 centimeter in diameter,
primarily in the upper lung zones. Often, simple silicosis is not associated with symptoms, detectable changes in lung
function or disability. Simple silicosis may be progressive and may develop into complicated silicosis or progressive
massive fibrosis (PMF).




Page 4
Badger Mining Corporation Last Revised: March 2007
MSDS for Silica Sand

Complicated silicosis or PMF is characterized by lung lesions (shown as radiographic opacities) greater than 1
centimeter in diameter. Although there may be no symptoms associated with complicated silicosis or PMF, the
symptoms, if present, are shortness of breath, wheezing, cough and sputum production. Complicated silicosis or PMF
may be associated with decreased lung function and may be disabling. Advanced complicated silicosis or PMF may
lead to death. Advanced complicated silicosis or PMF can result in heart disease (cor pumonale) secondary to the lung
disease.

Accelerated Silicosis can occur with exposure to high concentrations of respirable crystalline silica over a relatively
short period; the lung lesions can appear within five (5) years of the initial exposure. The progression can be rapid.
Accelerated silicosis is similar to chronic or ordinary silicosis, except that the lung lesions appear earlier and the
progression is more rapid.

Acute Silicosis can occur with exposures to very high concentrations of respirable crystalline silica over a very short
time period, sometimes as short as a few months. The symptoms of acute silicosis include progressive shortness of
breath, fever, cough and weight loss. Acute silicosis is fatal.

B. CANCER
IARC - The International Agency for Research on Cancer ("IARC") concluded that there was "sufficient evidence in
humans for the carcinogenicity of crystalline silica in the forms of quartz or cristobalite from occupational sources",
and that there is "sufficient evidence in experimental animals for the carcinogenicity of quartz and cristobalite." The
overall IARC evaluation was that "crystalline silica inhaled in the form of quartz or cristobalite from occupational
sources is carcinogenic to humans (Group 1)." The IARC evaluation noted that not all industrial circumstances studied
evidenced carcinogenicity. The monograph also stated that 鈥淸C]arcinogenicity may be dependent on inherent
characteristics of the crystalline silica or on external factors affecting its biological activity or distribution of its
polymorphs." For further information on the IARC evaluation, see IARC Monographs on the Evaluation of Carcinogenic
Risks to Humans, Volume 68, "Silica, Some Silicates..." (1997).

NTP - The National Toxicology Program, in its Ninth Annual Report on Carcinogens, concluded that respirable
crystalline silica is known to be a human carcinogen, based on sufficient evidence of carcinogenicity from studies in
humans indicating a causal relationship between exposure to respirable crystalline silica and increased lung cancer
rates in workers exposed to crystalline silica dust.

OSHA 鈥? Not regulated as a carcinogen.

There have been many articles published on the carcinogenicity of crystalline silica, which the reader should consult
for additional information; the following are examples of recently published articles: (1) 鈥淟ung cancer among
industrial sand workers exposed to crystalline silica鈥?, Am J Epidemiol, (153) 695-703 (2001); (2) "Crystalline Silica
and the risk of lung cancer in the potteries", Occup Environ Med, (55) 779-785 (1998); (3) "Is Silicosis Required for
Silica-Associated Lung Cancer?", American Journal of Industrial Medicine, (37) 252- 259 (2000); (4) " Silica, Silicosis,
and Lung Cancer: A Risk Assessment", American Journal of Industrial Medicine, (38) 8-18 (2000); (5) "Silica, Silicosis,
and Lung Cancer: A Response to a Recent Working Group Report", Journal of Occupational and Environmental
Medicine, (42) 704-720 (2000).

C. AUTOIMMUNE DISEASES
There is evidence that exposure to respirable crystalline silica (without silicosis) or that the disease silicosis may be
associated with the increased incidence of several autoimmune disorders, -- scleroderma, systemic lupus
erythematosus, rheumatoid arthritis and diseases affecting the kidneys. For a review of the subject, the following may
be consulted: "Occupational Exposure to Crystalline Silica and Autoimmune Disease", Environmental Health
Perspectives, (107) Supplement 5, 793-802 (1999); "Occupational Scleroderma", Current Opinion in Rheumatology,
(11) 490-494 (1999); 鈥淐onnective tissue disease and silicosis鈥?, Am J Ind Med, (35), 375-381 (1999).

D. TUBERCULOSIS
Individuals with silicosis are at increased risk to develop pulmonary tuberculosis, if exposed to persons with
tuberculosis. The following may be consulted for further information: Occupational Lung Disorders, Third Edition,
Chapter 12, entitled "Silicosis and Related Diseases", Parkes, W. Raymond (1994); "Risk of pulmonary tuberculosis
relative to silicosis and exposure to silica dust in South African gold miners," Occup Environ Med, (55) 496-502
(1998); 鈥淥ccupational risk factors for developing tuberculosis鈥?, Am J Ind Med, (30) 148-154 (1996).




Page 5
Badger Mining Corporation Last Revised: March 2007
MSDS for Silica Sand

E. KIDNEY DISEASE
There is evidence that exposure to respirable crystalline silica (without silicosis) or that the disease silicosis is
associated with the increased incidence of kidney diseases, including end stage renal disease. For additional
information on the subject, the following may be consulted: "Kidney Disease and Silicosis", Nephron, (85) 14-19
(2000); 鈥淓nd stage renal disease among ceramic workers exposed to silica鈥?, Occup Environ Med, (56) 559-561
(1999); 鈥淜idney disease and arthritis in a cohort study of workers exposed to silica鈥?, Epidemiology, (12) 405-412
(2001).

F. NON-MALIGNANT RESPIRATORY DISEASES
NIOSH has cited the results of studies that report an association between dusts found in various mining operations and
non-malignant respiratory disease, particularly among smokers, including bronchitis, emphysema, and small airways
disease. The results were not conclusive regarding an association among those with silicosis, only smokers, or the
result of general mineral dust that does not contain silica. See NIOSH Hazard Review 鈥? Health Effects of Occupational
Exposure to Respirable Crystalline Silica, published in April 2002, available from NIOSH, 4676 Columbia Parkway,
Cincinnati, OH 45226, or at http://www.cdc.gov/niosh/02-129A.html.


Section 12 鈥? Ecological Information
Crystalline silica is not known to be ecotoxic.

Section 13 鈥? Disposal Considerations
General: Crystalline silica may be landfilled. Material should be placed in covered containers to minimize
generation of airborne dust.

RCRA: Crystalline silica (quartz) is not classified as a hazardous waste under the Resource Conservation
and Recovery Act, or its regulations, 40 CFR 搂261 et seq.

The above information applies to Badger Mining Corporation Silica Sand only as sold. The product may be
contaminated during use, and it is the responsibility of the user to assess the appropriate disposal method in this
situation.

Section 14 鈥? Transport Information
Crystalline silica (quartz) is not a hazardous material for purposes of transportation under the U. S. Department of
Transportation Table of Hazardous Materials, 49 CFR 搂172.101.

Section 15 鈥? Regulatory Information
UNITED STATES (FEDERAL AND STATE)
TSCA No.: Crystalline silica (quartz) appears on the EPA TSCA inventory under the CAS No. 14808-60-7.
RCRA: Crystalline silica (quartz) is not classified as a hazardous waste under the Resource Conservation and
Recovery Act, or its regulations, 40 CFR 搂261 et seq.
CERCLA: Crystalline silica (quartz) is not classified as a hazardous substance under regulations of the
Comprehensive Environmental Response Compensation and Liability Act (CERCLA), 40 CFR 搂302.
Emergency Planning and Community Right to Know Act: Crystalline silica (quartz) is not an extremely
hazardous substance under Section 302 and is not a toxic chemical subject to the requirements of Section
313.
Clean Air Act: Crystalline silica (quartz) mined and processed by Badger Mining Corporation was not
processed with or does not contain any Class I or Class II ozone depleting substances.
FDA: Silica is included in the list of substances that may be included in coatings used in food contact surfaces,
21 CFR 搂175.300(b)(3)(xxvi).
NTP: Respirable crystalline silica (quartz) is classified as a known human carcinogen.
OSHA Carcinogen: Crystalline silica (quartz) is not listed.
California Proposition 65: Crystalline silica (quartz) is classified as a substance known to the state of
California to be a carcinogen.
California Inhalation Reference Exposure Limit (REL): The California chronic REL for respirable crystalline
silica is 3 ug/m3. A chronic REL is an airborne level of a substance at or below which no adverse health
effects are anticipated in individuals indefinitely exposed to the substance at that level.
Massachusetts Toxic Use Reduction Act: Respirable crystalline silica is considered toxic per the Massachusetts
Toxic Use Reduction Act.


Page 6
Badger Mining Corporation Last Revised: March 2007
MSDS for Silica Sand

Pennsylvania Worker and Community Right to Know Act: Quartz is considered hazardous for purposes of the
Act, but it is not a special hazardous substance or an environmental hazardous substance.

CANADA
Domestic Substances List: Badger Mining Corporation products, as naturally occurring substances, are on the
Canadian DSL.
WHMIS Classification: D-2A

OTHER
EINECS No.: 231-545-4
EEC Label (Risk/Safety Phrases): R 48/20, R 40/20, S22, S38
IARC: Crystalline silica (quartz) is classified in IARC Group 1.
National, state, provincial or local emergency planning, community right to know or other laws, regulations
or ordinances may be applicable--consult applicable national, state, provincial or local laws.

Section 16 鈥? Other Information
An electronic version of this MSDS is available at www.badgerminingcorp.com . More information on the effects of
crystalline silica exposure may be obtained from the Occupational Safety and Health Administration (OSHA) (phone
number: 1-800-321-OSHA; website: http://www.osha.gov) or from the National Institute for Occupational Safety
and Health (NIOSH) (phone number: 1-800-35-NIOSH; website: http://www.cdc.gov/niosh).

HMIS:
Health: See Section 2 and Section 11 of this MSDS.
Flammability: 0
Reactivity: 0
Protective Equipment: E

NFPA
Health: 0
Flammability: 0
Reactivity: 0




Page 7

ALL Chemical Analysis PAGES IN THIS GROUP
NAMECAS
7727-37-9.asp 7727-37-9
7439-97-6.asp 7439-97-6
04-12-0.asp 04-12-0 1344-28-1
04-10-0.asp 04-10-0 64742-48-9 64742-47-8 108-88-3 1330-20-7 100-41-4 108-67-8 95-63-6 13463-67-7 14807-96-6 110-19-0 108-65-6 112926-00-8
10102-44-0.asp 10102-44-0 7782-44-7 7727-37-9
64-17-5.asp 64-17-5 56-95-1
badgerminingcorp_com_March12007SilicaSandMSDSRevE.asp N/A
8052-41-3.asp 8052-41-3 64742-95-6 112945-52-5 64742-04-7
8052-42-4.asp 8052-42-4
7440-59-7.asp 7440-59-7
bangslabs_com_MSDS_PMMA.asp N/A
27012-62-0.asp 27012-62-0 107-13-1
15-02-2.asp 15-02-2 7439-92-1 7440-36-0 7664-93-9 9003-56-9
batzner_com_PT221LLabel.asp N/A
1405-97-6.asp 1405-97-6 1405-10-3 1405-20-5 54-64-8
3063-94-3.asp 3063-94-3 17096-07-0 19875-51-9 70877-62-2 79-41-4 13050-09-0 131-54-4 2035-72-5
32986-56-4.asp 32986-56-4 10043-35-3 7732-18-5
72822-13-0.asp 72822-13-0
67-63-0.asp 67-63-0 7732-18-5
9004-54-0.asp 9004-54-0 9004-65-3 8001-54-5 7732-18-5
67-63-0.asp 67-63-0
557-04-0.asp 557-04-0 9002-89-5 108-05-4
138261-41-3.asp 138261-41-3 1344-28-1
5742-19-8.asp 5742-19-8 111-42-2
064700-56-7.asp 064700-56-7
136426-54-5.asp 136426-54-5
26225-79-6.asp 26225-79-6
39148-24-8.asp 39148-24-8 112926-00-8
52645-53-1.asp 52645-53-1 14807-96-6
40596-69-8.asp 40596-69-8 64742-94-5
67485-29-4.asp 67485-29-4 57-55-6
120068-37-3.asp 120068-37-3 112-34-5
138261-41-3.asp 138261-41-3 55965-84-9
25606-41-1.asp 25606-41-1
138261-41-3.asp 138261-41-3 112926-00-8 128-37-0
5836-29-3.asp 5836-29-3
95737-68-1.asp 95737-68-1 57-55-6
138261-41-3.asp 138261-41-3 61827-42-7
13194-48-4.asp 13194-48-4 68412-54-4 68953-96-8
178928-70-6.asp 178928-70-6 118134-30-8
39148-24-8.asp 39148-24-8 27458-92-0
55-38-9.asp 55-38-9 1330-20-7
138261-41-3.asp 138261-41-3
1309-37-1.asp 1309-37-1 1333-86-4 7439-96-5 7440-21-3 7440-02-0 7440-50-8 7440-47-3 7439-98-7 1314-62-1
7758-99-8.asp 7758-99-8
bccytometry_com_732537AA.asp N/A
50-00-0.asp 50-00-0
50-00-0.asp 50-00-0
26628-22-8.asp 26628-22-8
910030-30-9.asp 910030-30-9


HBCChem,Inc

Chemical Information Net chemcas.orgCopyright Reserved

Trading Lead

Leputech HPLC Laboratory